| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Case of Acute Tubular Necrosis Following Administration of Carbidopa-Levodopa
|
Scetta, S.
|
|
|
134 |
C |
p.
|
artikel
|
| 2 |
A Case of Palatal Myoclonus Associated with Psychological Factors: A Clinical Observation
|
Akin, M.A.
|
|
|
134 |
C |
p.
|
artikel
|
| 3 |
A case of probable Progressive Supranuclear Palsy Frontal type (PSP-F) presenting as psychosis
|
Bashir, A.
|
|
|
134 |
C |
p.
|
artikel
|
| 4 |
A deep learning approach for classifying REM sleep behavior disorder using EEGNet
|
Jung, Y.J.
|
|
|
134 |
C |
p.
|
artikel
|
| 5 |
Allogenic transplantation therapy of iPS cell-derived dopamine progenitors for Parkinson’s disease -Current status and future perspectives
|
Takahashi, R.
|
|
|
134 |
C |
p.
|
artikel
|
| 6 |
Alzheimer's Co-Pathology burden on Basal Forebrain Atrophy and Cognitive Function in Lewy Body Dementia
|
Giannelli, T.
|
|
|
134 |
C |
p.
|
artikel
|
| 7 |
Analysis of caregiver overload in atypical Parkinsonisms
|
Cámara, A.
|
|
|
134 |
C |
p.
|
artikel
|
| 8 |
Analysis of interleukin-6 levels in patients with Parkinson's disease by disease stage
|
Muminov, B.A.
|
|
|
134 |
C |
p.
|
artikel
|
| 9 |
Analysis of mortality from Parkinson's Disease: variations between sex, year of death and regional distribution by age over 27 years
|
Fortaleza Falcão, M.
|
|
|
134 |
C |
p.
|
artikel
|
| 10 |
An Analysis of Biopsy Number in the Detection of Cutaneous Phosphorylated Alpha-Synuclein
|
Levine, T.
|
|
|
134 |
C |
p.
|
artikel
|
| 11 |
A New Method for the Evaluation of Cervical Dystonia
|
Karakaya, H.
|
|
|
134 |
C |
p.
|
artikel
|
| 12 |
A noninterventional study to evaluate real-world feasibility, compliance, and satisfaction with digital health technologies for Parkinson’s disease
|
Abid, N.
|
|
|
134 |
C |
p.
|
artikel
|
| 13 |
Aβ42, Not Opening-Closing Pressure Differences, Predicts Clinical Outcome After Large-Volume Lumbar Puncture in Suspected Normal Pressure Hydrocephalus
|
Jung, S.Y.
|
|
|
134 |
C |
p.
|
artikel
|
| 14 |
A Novel Diagnostic Method for Detection and Quantitation of Cutaneous Phosphorylated Alpha-Synuclein
|
Bellaire, B.
|
|
|
134 |
C |
p.
|
artikel
|
| 15 |
A Novel Missense Mutation in the Spectrin Repeat of SPTBN2 Identified in Spinocerebellar Ataxia Type 5
|
Yasar, S.
|
|
|
134 |
C |
p.
|
artikel
|
| 16 |
A Novel SYNE 1 gene mutation in several members of a Turkish Family
|
Genç, G.
|
|
|
134 |
C |
p.
|
artikel
|
| 17 |
Anti-Amphiphysin-IgG-seropositive paraneoplastic syndrome: a rare cause of Stiff Person Syndrome
|
Intini, D.
|
|
|
134 |
C |
p.
|
artikel
|
| 18 |
A Personalized, Network-Based FDG-PET Classification Algorithmic Framework for Differential Diagnosis of Neurodegenerative Disorders: Development and Validation
|
Petek, G.
|
|
|
134 |
C |
p.
|
artikel
|
| 19 |
A peruvian cohort of patients with Multiple System Atrophy
|
Nunez, Y.
|
|
|
134 |
C |
p.
|
artikel
|
| 20 |
APOE carrier status and cognitive outcomes after STN-DBS surgery for Parkinson’s disease.
|
O’Shea, S.A.
|
|
|
134 |
C |
p.
|
artikel
|
| 21 |
A randomized, controlled study of the add-on effect of selegiline or zonisamide to L-dopa/DCI therapy in Parkinson's disease (DATSZ-PD study)
|
Makio, T.
|
|
|
134 |
C |
p.
|
artikel
|
| 22 |
A RARE PRESENTATION OF HYPERTROPHIC PACHYMENINGITIS IN ASSOCIATION WITH LEVODOPA RESPONSIVE PARKINSON’S DISEASE
|
Manikinda, J.
|
|
|
134 |
C |
p.
|
artikel
|
| 23 |
A rare presentation of upper facial chorea in huntington disease
|
Anjaneyulu, K.
|
|
|
134 |
C |
p.
|
artikel
|
| 24 |
A retrospective study of mobilization of inpatients with Parkinson’s disease
|
Gunzler, S.A.
|
|
|
134 |
C |
p.
|
artikel
|
| 25 |
Are we ready for automated deep brain stimulation programming?
|
Cole, Eric R.
|
|
|
134 |
C |
p.
|
artikel
|
| 26 |
ASSESSING UPPER LIMB MOTOR FUNCTION IN PARKINSON’S DISEASE USING A NEW SMART STYLUS TECHNOLOGY IN AUGMENTED REALITY
|
Vanbellingen, T.
|
|
|
134 |
C |
p.
|
artikel
|
| 27 |
Assessment of bezisterim (NE3107) in patients with early Parkinson’s Disease: A phase 2, placebo-controlled study
|
Palumbo, J.
|
|
|
134 |
C |
p.
|
artikel
|
| 28 |
Assessment of Cerebral Cortical Atrophy Using Visual Rating Scale in Patients with Functional Movement Disorder
|
Eyigürbüz, T.
|
|
|
134 |
C |
p.
|
artikel
|
| 29 |
Association between age-related musculoskeletal diseases and Parkinson's disease: a population-based cohort study of UK Biobank
|
Yang, T.
|
|
|
134 |
C |
p.
|
artikel
|
| 30 |
Association Between Antiepileptic Drugs and Parkinson’s Disease: A Strong or Weak Link?
|
Kharel, S.
|
|
|
134 |
C |
p.
|
artikel
|
| 31 |
Association between baseline impulse control disorder and future levodopa induced dyskinesia in Parkinson’s disease: the PPMI cohort
|
Park, M.
|
|
|
134 |
C |
p.
|
artikel
|
| 32 |
A systematic review and meta-analysis of neutralizing antibodies after treatment with abobotulinumtoxinA, incobotulinumtoxinA and onabotulinumtoxinA across multiple indications
|
Walter, U.
|
|
|
134 |
C |
p.
|
artikel
|
| 33 |
A Twist in the Treatment Tale: Repurposing Drugs to Conquer Parkinson’s
|
Arulalan, S.
|
|
|
134 |
C |
p.
|
artikel
|
| 34 |
Authors' reply to “Comment on Chaparro-Solano et al.: ‘Critical evaluation of the current landscape of pharmacogenomics in Parkinson's disease – What is missing? A systematic review’”
|
Chaparro-Solano, Henry Mauricio
|
|
|
134 |
C |
p.
|
artikel
|
| 35 |
Autoimmune Rarities: Myasthenia Gravis and Parkinson's disease after inflammatory myopathy
|
Eyigürbüz, T.
|
|
|
134 |
C |
p.
|
artikel
|
| 36 |
Automated Deep Brain Stimulation Parameter Selection via Meta-Active Learning of Evoked Potentials
|
Cole, E.R.
|
|
|
134 |
C |
p.
|
artikel
|
| 37 |
Automatic Speech Analysis for Detecting Speech Deficits in isolated REM sleep behavior disorder, Parkinson’s disease, and progressive supranuclear palsy
|
Thies, T.
|
|
|
134 |
C |
p.
|
artikel
|
| 38 |
A young man with progressive dysarthria, generalized slowness and memory loss
|
Phuenpathom, W.
|
|
|
134 |
C |
p.
|
artikel
|
| 39 |
Big data and transformative bioinformatics in genomic diagnostics and beyond
|
Saparov, Alice
|
|
|
134 |
C |
p.
|
artikel
|
| 40 |
Bilateral pallidal deep brain stimulation for generalized dystonia in a patient with novel variants in the VPS16 gene.
|
Radhakrishnan, D.M.
|
|
|
134 |
C |
p.
|
artikel
|
| 41 |
Bilateral thalamic cysts as a delayed complication of radiosurgical treatment in a patient with Parkinson’s disease
|
Gamaleya, A.
|
|
|
134 |
C |
p.
|
artikel
|
| 42 |
Botulinum toxin-responsive apraxia of eyelid opening: A Case Report and Short Review of Literature
|
Doğan Yelkenci, C.
|
|
|
134 |
C |
p.
|
artikel
|
| 43 |
Brain hypometabolism and clinical features of GBA individuals
|
Gallo, L.
|
|
|
134 |
C |
p.
|
artikel
|
| 44 |
Building University-based Wellness & Exercise Programs for Individuals with Parkinson’s Disease
|
States, R.A.
|
|
|
134 |
C |
p.
|
artikel
|
| 45 |
Can a Ketogenic Diet Alter the Course of Parkinson’s Disease?
|
Hitawala, G.
|
|
|
134 |
C |
p.
|
artikel
|
| 46 |
Can a Parkinson’s Disease Inpatient Program Improve Quality of Care During Elective Surgical Admissions?
|
Stepanyants, V.
|
|
|
134 |
C |
p.
|
artikel
|
| 47 |
Case Report: New Onset Hyperkinetic Movement Disorder in IgA Lambda Myeloma
|
Agarwal, U.
|
|
|
134 |
C |
p.
|
artikel
|
| 48 |
Cathepsin L-containing exosomes from α-synuclein-activated microglia induce neurotoxicity through the P2X7 receptor
|
Jiang, T.
|
|
|
134 |
C |
p.
|
artikel
|
| 49 |
Cell based therapy to generate dopaminergic neuron precursor cells
|
Sachin, Srikaran
|
|
|
134 |
C |
p.
|
artikel
|
| 50 |
Characteristics of incobotulinumtoxinA treatment for cervical dystonia in a real-world setting: Dosing and muscles injected
|
Holmes, J.
|
|
|
134 |
C |
p.
|
artikel
|
| 51 |
Characteristics of incobotulinumtoxinA treatment for limb spasticity in a real-world setting: Dosing and muscles injected
|
Holmes, J.
|
|
|
134 |
C |
p.
|
artikel
|
| 52 |
Cholinergic basal forebrain atrophy and cortical alterations in Parkinson's disease with apathy
|
Si, Qianqian
|
|
|
134 |
C |
p.
|
artikel
|
| 53 |
Clinical and genealogical features of parkinson's disease
|
Daminova, H.
|
|
|
134 |
C |
p.
|
artikel
|
| 54 |
Clinical effectiveness of monitoring of daily symptoms in patients with Parkinson’s disease by smartphone application with wearable device: SHARE-PD study
|
Oyama, G.
|
|
|
134 |
C |
p.
|
artikel
|
| 55 |
Clinical manifestations and efficacy of deep brain stimulation in children with medically refractory hereditary movement disorders
|
Dai, L.
|
|
|
134 |
C |
p.
|
artikel
|
| 56 |
Clinical profile of GBA K198E Carriers compared with Other GBA Variants in a Colombian Cohort from LARGE-PD
|
Lopez, T.
|
|
|
134 |
C |
p.
|
artikel
|
| 57 |
Clinical Progression and Genetic Pathways in Body-First and Brain-First Par-kinson’s Disease
|
Passaretti, M.
|
|
|
134 |
C |
p.
|
artikel
|
| 58 |
Clinical progression of vascular Parkinsonism in ischemic stroke patients with metabolic syndrome
|
Usmonova, S.B.
|
|
|
134 |
C |
p.
|
artikel
|
| 59 |
CLIPPERS syndrom is a recently defined inflammatory central nervous system disorder, prominently involving the brainstem and in particular the pons.
|
Abdullazizova, U.
|
|
|
134 |
C |
p.
|
artikel
|
| 60 |
Closing the loop in DBS: A data-driven approach
|
Acharyya, Prerana
|
|
|
134 |
C |
p.
|
artikel
|
| 61 |
Coffee and Constipation in Parkinson's Disease
|
Huynh, D.
|
|
|
134 |
C |
p.
|
artikel
|
| 62 |
Coffee consumption linked to delayed age at onset of Parkinson’s disease
|
Senkevich, K.
|
|
|
134 |
C |
p.
|
artikel
|
| 63 |
Cognitive outcomes of subthalamic versus pallidal deep brain stimulation in Parkinson’s disease patients aged 70 years and older
|
Amstutz, D.
|
|
|
134 |
C |
p.
|
artikel
|
| 64 |
Coherent single cell oscillations in the subthalamic nucleus relate to clinical asymmetry in Parkinsonian patients
|
Golik, A.
|
|
|
134 |
C |
p.
|
artikel
|
| 65 |
Colony-Stimulating Factor-1 Receptor-Related Disorders in the Hispanic Population: A Report of six Families
|
Chmiela, T.
|
|
|
134 |
C |
p.
|
artikel
|
| 66 |
Comment on Chaparro-Solano et al.: “Critical evaluation of the current landscape of pharmacogenomics in Parkinson's disease - What is missing? A systematic review.” Parkinsonism Relat Disord. 2025 Jan;130:107206
|
Loonen, Anton J.M.
|
|
|
134 |
C |
p.
|
artikel
|
| 67 |
Comparative analysis of opicapone and entacapone in the management of motor fluctuations in patients with Parkinson’s disease
|
Kremens,
|
|
|
134 |
C |
p.
|
artikel
|
| 68 |
COMPARATIVE ANALYSIS OF SERUM ALPHA-SYNUCLEIN LEVELS IN PARKINSON'S DISEASE AND ESSENTIAL TREMOR GROUPS
|
Eshankulova, N.Y.
|
|
|
134 |
C |
p.
|
artikel
|
| 69 |
Comparison of DBS-STN, LCIG and LECIG in advanced Parkinson’s disease patients: A One-Year Study
|
Hero, M.
|
|
|
134 |
C |
p.
|
artikel
|
| 70 |
Comparison of Regional Enlarged Perivascular Spaces in Parkinson’s Disease and Essential Tremor
|
Cinar, S.
|
|
|
134 |
C |
p.
|
artikel
|
| 71 |
Comparison of the effects of levodopa/carbidopa and foslevodopa/foscarbidopa pump on the quality of life and sleep in Parkinson’s disease patients
|
Andrić, R. Brnić
|
|
|
134 |
C |
p.
|
artikel
|
| 72 |
Complex Presentation of Parkinsonism in a Patient with Baló Concentric Sclerosis
|
Pesantez Pacheco, L.
|
|
|
134 |
C |
p.
|
artikel
|
| 73 |
Comprehensive analysis of SLC17A5 variants in large European cohorts reveals no association with Parkinson's disease risk
|
Sabir, Marya S.
|
|
|
134 |
C |
p.
|
artikel
|
| 74 |
Concordance between imaging and clinical based STN-DBS programming improves motor outcomes of directional stimulation in Parkinson’s disease.
|
Rigon, L.
|
|
|
134 |
C |
p.
|
artikel
|
| 75 |
Continuous Subcutaneous Apomorphine Infusion (CSAI) Improved Confidence When Engaging in Everyday Activities: Survey of InfusON Study Participants
|
Agarwal, P.
|
|
|
134 |
C |
p.
|
artikel
|
| 76 |
Continuous subcutaneous foslevodopa - foscarbidopa infusion therapy for advanced Parkinson's disease –a single centre experience
|
Ibrulj, S.
|
|
|
134 |
C |
p.
|
artikel
|
| 77 |
Correlation between sleep and quality of life in people with Parkinson’s disease treated with continuous subcutaneous infusion of foslevodopa/foscarbidopa
|
Malaty, I.
|
|
|
134 |
C |
p.
|
artikel
|
| 78 |
Correlation of clinical scores with remote assessments of accelerometry output of a low-cost quantitative continuous measurement of movements
|
Elshourbagy, A.
|
|
|
134 |
C |
p.
|
artikel
|
| 79 |
Correlations of neurotrophic factors concentration with the clinical demonstration and progression of patients with Parkinson’s Disease – preliminary study.
|
Węgrzynek-Gallina, J.
|
|
|
134 |
C |
p.
|
artikel
|
| 80 |
Corrigendum to “Variable expressivity of KMT2B variants at codon 2565 in patients with dystonia and developmental disorders” [Parkinson. Relat. Disord. (2025) 133 107319]
|
Stehr, Antonia M.
|
|
|
134 |
C |
p.
|
artikel
|
| 81 |
Cortical Activation And Network Changes in Cognitive Impairment of Parkinson’s Disease: Insights from fNIRS
|
Zhao, J.
|
|
|
134 |
C |
p.
|
artikel
|
| 82 |
Cortical inhibitory and facilitatory alterations in the continuum of alpha-synucleinopathies
|
Rizzardi, A.
|
|
|
134 |
C |
p.
|
artikel
|
| 83 |
Cortical Myelination Patterns Differentiate Freezing of Gait in Parkinson's Disease Progression
|
Rathi, G.N.
|
|
|
134 |
C |
p.
|
artikel
|
| 84 |
Cortical, thalamic and subthalamic electrophysiologic response to peripheral stimulation in patients with movement disorders
|
Borgheai, S.B.
|
|
|
134 |
C |
p.
|
artikel
|
| 85 |
Cracking the Circular Code: Unveiling the Role of circRNAs in Parkinson’s Disease
|
Saravanan, G.
|
|
|
134 |
C |
p.
|
artikel
|
| 86 |
CSM-101, a small molecule agonist of TRPML1 for Parkinson’s-related disorders
|
Murphy, L.O.
|
|
|
134 |
C |
p.
|
artikel
|
| 87 |
Cystatin C as a Biomarker for the Development of Parkinson disease in Patients with Chronic Kidney Disease
|
Khudayarova, S.M.
|
|
|
134 |
C |
p.
|
artikel
|
| 88 |
Deep Brain Stimulation Using Microelectrode Recording for Movement Disorders: Puerto Rico experience
|
Pérez-Luciano, E.
|
|
|
134 |
C |
p.
|
artikel
|
| 89 |
Demonstration of a Prototype Clinical Decision Support System for Diagnosing Parkinson’s Disease
|
Iyer, V.
|
|
|
134 |
C |
p.
|
artikel
|
| 90 |
Description Genotype/phenotype of patients with Parkinson's disease. Report of an Argentinean cohort included in the LARGE-PD consortium.
|
Espindola, M.
|
|
|
134 |
C |
p.
|
artikel
|
| 91 |
Descriptive Analysis of an Interdisciplinary Palliative Care Clinic for Advanced Parkinson's Disease
|
Lopez, T.
|
|
|
134 |
C |
p.
|
artikel
|
| 92 |
Determining the Abundance of α-synuclein in Rat Erythrocytes and Brain Homogenates - A Step Towards Non-invasive Detection for Parkinson's Disease
|
Leo, A.
|
|
|
134 |
C |
p.
|
artikel
|
| 93 |
Developing a Female-Specific Mouse Model for Parkinson’s Disease Using a High-Sensitivity Neural Network
|
Kane, P.W.
|
|
|
134 |
C |
p.
|
artikel
|
| 94 |
Development of the Parkinsonism Atypical Features Assessment (PAFA)
|
Moondra, P.
|
|
|
134 |
C |
p.
|
artikel
|
| 95 |
Device-aided therapies (DATs) in Parkinson´s disease (PD). The DATs-PD GETM Spanish Registry.
|
Santos-García, D.
|
|
|
134 |
C |
p.
|
artikel
|
| 96 |
Diagnostic challenges in a young patient with diplopia: functional near reflex spasm
|
Eyigürbüz, T.
|
|
|
134 |
C |
p.
|
artikel
|
| 97 |
Dietary restrictions and pattern influence on Parkinson's disease
|
Sachin, Srikaran
|
|
|
134 |
C |
p.
|
artikel
|
| 98 |
Differences in the Prevalence of Sleep Fragmentation and Other Baseline Sleep Characteristics in Genetic PD Subgroups
|
Yang, M.
|
|
|
134 |
C |
p.
|
artikel
|
| 99 |
Digital Measures for Clinical Trial Endpoints in Huntington’s Disease (MEND-HD): Study Design and Methods
|
Adams, J.L.
|
|
|
134 |
C |
p.
|
artikel
|
| 100 |
Digital Speech Biomarkers to guide STN-DBS programming
|
Sousa, M.
|
|
|
134 |
C |
p.
|
artikel
|
| 101 |
Directional stimulation in subthalamic DBS for Parkinson’s disease: finding an application for novel technology
|
Gamaleya, A.
|
|
|
134 |
C |
p.
|
artikel
|
| 102 |
Discovery of customer needs for technology to distinguish Parkinson’s disease from related conditions
|
Brašić, J.R.
|
|
|
134 |
C |
p.
|
artikel
|
| 103 |
Disturbed rest-activity rhythm in Parkinson’s disease: associations with motor severity and orthostatic hypotension
|
Mijnsbergen, M.D.
|
|
|
134 |
C |
p.
|
artikel
|
| 104 |
Does Pharmacological Optimization Influence The Outcomes Of Inpatient Multimodal Intensive Care? A Study In Patients With Moderately Advanced Parkinson’s Disease
|
Elayan, N.
|
|
|
134 |
C |
p.
|
artikel
|
| 105 |
Dopamine responsive parkinsonism and positive DaTscan in Jacob’s syndrome (47, XYY)
|
Tsutsumi, K.
|
|
|
134 |
C |
p.
|
artikel
|
| 106 |
Dopaminergic dysfunctions instigated by Nano-formulation of Neonicotinoid pesticides in mice
|
Borkar, D.S.
|
|
|
134 |
C |
p.
|
artikel
|
| 107 |
Dopamine Transporter Activity and Autonomic Dysfunction and in Parkinson’s Disease
|
Cheon, S.M.
|
|
|
134 |
C |
p.
|
artikel
|
| 108 |
Dual Phase 18F-FP-CIT PET in presynaptic and trans-synaptic nigrostriatal dysfunction in Multiple System Atrophy
|
Kim, Y.S.
|
|
|
134 |
C |
p.
|
artikel
|
| 109 |
Duration of “Good On” time per dose: Immediate-release carbidopalevodopa vs. extended-release carbidopa-levodopa (IPX203, CREXONT®)
|
Hauser, R.A.
|
|
|
134 |
C |
p.
|
artikel
|
| 110 |
Dystonia Cases Diagnosed at a Specialized Movement Disorders Center in Chile: Epidemiological and Clinical Insights
|
Peña, S.
|
|
|
134 |
C |
p.
|
artikel
|
| 111 |
Dystonia induced by combination of oxycodone with duloxetine, and escitalopram in two patients: role of genetic variation at CYP2D6 and
|
Sarac, I.
|
|
|
134 |
C |
p.
|
artikel
|
| 112 |
Early diagnosis of cognitive impairment in patients with Parkinson's disease
|
Okhunova, D.A.
|
|
|
134 |
C |
p.
|
artikel
|
| 113 |
Early-onset Parkinson's disease, regional and national burden, and its attributable risk factors in 204 countries and regions from 1990 to 2021: Results from the global burden of disease study 2021
|
Wang, Jiayue
|
|
|
134 |
C |
p.
|
artikel
|
| 114 |
Early versus delayed Deep Brain Stimulation: correlation between patient age, symptoms and cost of therapy
|
Guerra, S.B.E.
|
|
|
134 |
C |
p.
|
artikel
|
| 115 |
Editorial Board
|
|
|
|
134 |
C |
p.
|
artikel
|
| 116 |
Educating and Empowering Under-engaged Communities on Implications of Genetic Status Using an Intergenerational and Wellness-based Approach
|
Aquino, E.
|
|
|
134 |
C |
p.
|
artikel
|
| 117 |
Educational Interventions on Parkinson’s Disease for Staff in Care Home Settings: A Scoping Review
|
Mitchell, G.
|
|
|
134 |
C |
p.
|
artikel
|
| 118 |
Effectiveness of a Multidisciplinary Rehabilitation Program in Improving Motor Function and Quality of Life in Parkinson's Disease Patients
|
Akbarkhodjaeva, Z.A.
|
|
|
134 |
C |
p.
|
artikel
|
| 119 |
Effectiveness of dynamic neuromuscular stabilization (DNS) training with balance training for Parkinson’s Disease patients on balance and gait abilities
|
Lin, S.Y.
|
|
|
134 |
C |
p.
|
artikel
|
| 120 |
Effectiveness of Photobiomodulation plus Exercise, to Enhance Motor Signs, and Quality of Life in Parkinson's Disease. (ClinicalTrials.gov: NCT06036433)
|
Saltmarche, A.
|
|
|
134 |
C |
p.
|
artikel
|
| 121 |
Effect of an adapted physical activity program in Parkinson's disease: A randomized controlled study (APA-Park)
|
Zanchet, Carole
|
|
|
134 |
C |
p.
|
artikel
|
| 122 |
Effect of Antidepressant Therapy on Non-Motor Symptoms in Parkinson’s Disease: A Cross-Sectional Study
|
Saxena, S.
|
|
|
134 |
C |
p.
|
artikel
|
| 123 |
Effect of Combined theta-gamma frequency subthalamic nucleus stimulation on verbal fluency in Parkinson disease: a randomized, double-blind, crossover study
|
Imbalzano, G.
|
|
|
134 |
C |
p.
|
artikel
|
| 124 |
Effect of low frequency versus high frequency stimulation on freezing of gait in patients with Parkinson’s disease post deep brain
|
Panigrahi, M.
|
|
|
134 |
C |
p.
|
artikel
|
| 125 |
Effect of ND0612 Continuous Infusion on Motor Performance and Experiences of Daily Living in Patients With Parkinson’s Disease
|
Rascol, O.
|
|
|
134 |
C |
p.
|
artikel
|
| 126 |
Effect of Safinamide on Non-motor symptoms and QoL According to Sex, Age, Disease Duration and Levodopa Equivalent Daily Dose
|
Santos-García, D.
|
|
|
134 |
C |
p.
|
artikel
|
| 127 |
Effect of trunk-centered rehabilitation program associated with specific brace in Parkinsonian with low back pain: A 6-year follow-up case report
|
David, Romain
|
|
|
134 |
C |
p.
|
artikel
|
| 128 |
Effect of Virtual Reality Meditation on Gait Parameters in Parkinson’s Disease Patients with Freezing of Gait: A Pilot Study
|
Phuenpathom, W.
|
|
|
134 |
C |
p.
|
artikel
|
| 129 |
Effects of an intensive, multidisciplinary rehabilitative treatment in an outpatient setting on clinical outcomes in Parkinson’s Disease: preliminary results.
|
Castagna, A.
|
|
|
134 |
C |
p.
|
artikel
|
| 130 |
Effects of dopaminergic therapy on swallowing physiology: electrokinesigraphic study in patients with Parkinson's disease.
|
Belluscio, G.
|
|
|
134 |
C |
p.
|
artikel
|
| 131 |
Effects of Interactive Stepping Exercise on Cognitive Function, Balance, and walking performance in Individuals with Parkinson's Disease
|
Liu, H.H.
|
|
|
134 |
C |
p.
|
artikel
|
| 132 |
Effects of Intestinal Infusion Therapies on Motor, Non-Motor and Laboratory Parameters in Advanced Parkinson's Disease: A Pilot Study
|
Straka, I.
|
|
|
134 |
C |
p.
|
artikel
|
| 133 |
Effects of OBA in a Castration-Based Model of Parkinson's Disease
|
Mohring, J.
|
|
|
134 |
C |
p.
|
artikel
|
| 134 |
Efficacy and safety of Fecal Microbiota Transplantation for Treatment of Parkinson's Disease: a meta-analysis of randomized controlled trials
|
Elrosasy, A.
|
|
|
134 |
C |
p.
|
artikel
|
| 135 |
Efficacy and Safety of Remote DBS Programming in Parkinson’s Disease - Interim Analysis from the REMOTE Trial
|
Shaik, J.
|
|
|
134 |
C |
p.
|
artikel
|
| 136 |
Efficacy of non-invasive cerebellar stimulation in patients with post-stroke dysphagia: a systematic review and meta-analysis with trial sequential analysis
|
Elrosasy, A.
|
|
|
134 |
C |
p.
|
artikel
|
| 137 |
Efficacy of Probiotics for treatment of constipation in Parkinson’s patients: a systematic review and meta-analysis
|
Alsaied, M.A.
|
|
|
134 |
C |
p.
|
artikel
|
| 138 |
Efficiency of carotid endarterectomy in vascular parkinsonism in patients with stenotic carotid artery disease
|
Abdullaev, J.D.
|
|
|
134 |
C |
p.
|
artikel
|
| 139 |
Electrocardiographic Markers of Autonomic Dysfunction in Parkinson’s Disease: A systematic Review and meta-analysis of Diagnostic and Prognostic Potential
|
Serag, I.
|
|
|
134 |
C |
p.
|
artikel
|
| 140 |
Enhancing Parkinson’s Disease Staging: Integrating Multiomic Analysis with α-Synuclein Seeding Aggregation Assays
|
Rumpf, S.L.
|
|
|
134 |
C |
p.
|
artikel
|
| 141 |
Enhancing pre-operative education for deep brain stimulation: evaluating the impact of online group webinars on patient outcomes
|
Boogers, A.
|
|
|
134 |
C |
p.
|
artikel
|
| 142 |
Enteric α-synuclein in Parkinson’s disease
|
Gao, V.
|
|
|
134 |
C |
p.
|
artikel
|
| 143 |
ERCC4 variants causing neurodegeneration with ataxia and chorea in three siblings in Lithuanian family
|
Jurkevičienė, J.
|
|
|
134 |
C |
p.
|
artikel
|
| 144 |
Error-based biofeedback for gait training in Parkinson's disease
|
Kolmykov, P.
|
|
|
134 |
C |
p.
|
artikel
|
| 145 |
Establishing the practical feasibility of expiratory muscle strength training (EMST) for individuals with Progressive Supranuclear Palsy (PSP)
|
Villarreal-Cavazos, K.
|
|
|
134 |
C |
p.
|
artikel
|
| 146 |
Evaluating Out-of-Pocket Costs for Specialty Medications in Parkinson’s Disease: A Comparative Study of Pimavanserin and Inhaled Levodopa
|
Henn, K.T.
|
|
|
134 |
C |
p.
|
artikel
|
| 147 |
Evaluating the Impact of Aripiprazole on Cognitive Functions in Patients with Parkinson’s Disease: a systematic review and meta analysis
|
Serag, I.
|
|
|
134 |
C |
p.
|
artikel
|
| 148 |
Evaluation Of Additive Neuroprotective Effect of Combination Therapy For Parkinson's Disease Using in Vitro Models
|
Shtilbans, A.
|
|
|
134 |
C |
p.
|
artikel
|
| 149 |
Evaluation of Crexont® (carbidopa/levodopa extended-release capsules) Tolerability and Efficacy in Patients with Parkinson’s Disease
|
Henn, K.T.
|
|
|
134 |
C |
p.
|
artikel
|
| 150 |
Evaluation of genetic alterations in MT-ND2 gene, common risk factors and clinical phenotypes in Parkinson's disease (PD) patients
|
Vellingiri, B.
|
|
|
134 |
C |
p.
|
artikel
|
| 151 |
Evaluation of Tremor in Spinocereballar Ataxia 12
|
Srivastava, K.
|
|
|
134 |
C |
p.
|
artikel
|
| 152 |
Evolution of Impulse Control Disorder in Spanish-Speaking People Living with Parkinson’s Disease: A Longitudinal Study
|
Náfate-Wences, D.
|
|
|
134 |
C |
p.
|
artikel
|
| 153 |
Expanded ATTCT-ATXN10 alleles in healthy Peruvian population
|
Araujo-Aliaga, I.
|
|
|
134 |
C |
p.
|
artikel
|
| 154 |
Expanding the phenotypic spectrum of ADCY5 related Disease.
|
MK, F.
|
|
|
134 |
C |
p.
|
artikel
|
| 155 |
exPDite-2: A randomized, sham-controlled, double-blind study to evaluate bemdaneprocel, a midbrain dopaminergic neuron progenitor cell therapy for Parkinson’s disease
|
Abid, N.
|
|
|
134 |
C |
p.
|
artikel
|
| 156 |
Experience with levodopa–entacapone–carbidopa intestinal infusion in Germany – interim results from the ELEGANCE study
|
Jost, W.H.
|
|
|
134 |
C |
p.
|
artikel
|
| 157 |
Exploring fMRI-Based Estimations of Saccadic Movements in SCA1 Patients
|
Pankaj, P.
|
|
|
134 |
C |
p.
|
artikel
|
| 158 |
Exploring long-term outcomes of a telehealth physical activity coaching program in Parkinson disease.
|
Wani, D.K.
|
|
|
134 |
C |
p.
|
artikel
|
| 159 |
Exploring Novel Therapeutic Approaches in Parkinson’s Disease: A Comprehensive Review
|
Beryl B, S.
|
|
|
134 |
C |
p.
|
artikel
|
| 160 |
Exploring the Feasibility of Conducting Outpatient Dopaminergic Washouts in Early-Stage Parkinson's Disease: Patient Experiences and Perspectives
|
Venditti, L.
|
|
|
134 |
C |
p.
|
artikel
|
| 161 |
Exploring the public perception and understanding of Parkinson's disease: an all-Ireland study
|
Crooks, S.
|
|
|
134 |
C |
p.
|
artikel
|
| 162 |
Exploring the role of NLRP3 activation in the Gut-Brain Axis Disruption in Parkinson’s disease and idiopathic REM sleep behavior disorder
|
Bellini, G.
|
|
|
134 |
C |
p.
|
artikel
|
| 163 |
Exploring the stigma experienced by people affected by Parkinson's disease: A systematic review
|
Crooks, S.
|
|
|
134 |
C |
p.
|
artikel
|
| 164 |
Exploring the Understudied Role of the Gut-Brain Axis and Microbiome in Parkinson’s Disease Pathology
|
Cheema, H.
|
|
|
134 |
C |
p.
|
artikel
|
| 165 |
Extracellular Fluid Patterns in the Basal Ganglia Reveal Distinct Motor Phenotypes in Parkinson’s Disease: A Machine Learning Approach
|
Vijayakumari, A.A.
|
|
|
134 |
C |
p.
|
artikel
|
| 166 |
Falls during a remote observational Parkinson's disease study: AT-HOME PD2 initial results
|
Auinger, P.
|
|
|
134 |
C |
p.
|
artikel
|
| 167 |
Feasibility and acceptability of Pre-Active PD: a Randomized Control Trial to Improve Physical Activity in People with Early-Stage Parkinson Disease
|
Long, K.
|
|
|
134 |
C |
p.
|
artikel
|
| 168 |
Feasibility and Safety of a Taekwondo Community-based Exercise Program for Older Adults and People with Parkinson’s Disease: A Pilot Study
|
Lombardi, J.
|
|
|
134 |
C |
p.
|
artikel
|
| 169 |
Feasibility of a Novel Maintenance Protocol for Airway Protective Treatment in Parkinson’s Disease
|
Veit, K.R.
|
|
|
134 |
C |
p.
|
artikel
|
| 170 |
18F-FDG PET findings in Parkinson's disease associated to RAB32 S71R variant
|
Cavallieri, Francesco
|
|
|
134 |
C |
p.
|
artikel
|
| 171 |
FindPD.DaT: Development of a Novel Artificial Intelligence-driven Tool for Diagnosis of Parkinson’s Disease using Dopamine Transporter Scans
|
Rajasekar, S.J.S.
|
|
|
134 |
C |
p.
|
artikel
|
| 172 |
First-in-human study to assess the safety, pharmacokinetics, and pharmacodynamics of ARV-102, a PROTAC LRRK2 degrader, in healthy volunteers
|
Smits, L.
|
|
|
134 |
C |
p.
|
artikel
|
| 173 |
Five-year changes in MDS-UPDRS-III and the gut microbiome in Parkinson’s disease with photobiomodulation treatment
|
Liebert, A.
|
|
|
134 |
C |
p.
|
artikel
|
| 174 |
Five-Year Open-Label Follow-Up of a Randomized Double-Blind Placebo-Controlled Trial of Helicobacter Pylori Eradication in Parkinson’s Disease
|
Tan, L.Y.
|
|
|
134 |
C |
p.
|
artikel
|
| 175 |
Fluid and Neuroimaging Biomarkers in Colony-Stimulating Factor-1 Receptor-Related Disorders
|
Chmiela, T.
|
|
|
134 |
C |
p.
|
artikel
|
| 176 |
Focal limb dystonia in Parkinson’s Disease triggered by sacral nerve stimulation: a case report
|
Yomtoob, J.
|
|
|
134 |
C |
p.
|
artikel
|
| 177 |
Foslevodopa/foscarbidopa continous infusion initiation in a hospitalized patient with intestinal occlusion
|
Tabar Comellas, G.
|
|
|
134 |
C |
p.
|
artikel
|
| 178 |
Foslevodopa infusion in Parkinson disease: a 20-week observation
|
Cocco, A.
|
|
|
134 |
C |
p.
|
artikel
|
| 179 |
Freezing of gait detection in Parkinson Disease using Head Kinematics and Eye Movements
|
Chen, J.
|
|
|
134 |
C |
p.
|
artikel
|
| 180 |
From Olympic Trials to Parkinson’s Disease: An Elite Runner’s Atypical 17-Year Marathon to Diagnosis
|
Stowers, J.
|
|
|
134 |
C |
p.
|
artikel
|
| 181 |
From Queasy to Rigid - An amendment on the administration of contraindicated antiemetics in hospitalized people with Parkinson's disease
|
Piccinin, Camila C.
|
|
|
134 |
C |
p.
|
artikel
|
| 182 |
Functional activity of apomorphine relative to dopamine at dopamine receptors: Findings from G protein coupled receptor biosensor assays
|
Yegla, B.
|
|
|
134 |
C |
p.
|
artikel
|
| 183 |
Gait Kinematics as Biomarkers of Preclinical Parkinson’s Disease: A Systematic Review of Sensor-Based Studies
|
Makhoul, K.
|
|
|
134 |
C |
p.
|
artikel
|
| 184 |
Gene therapy aimed at increasing parkin expression
|
Venkatesan, S.
|
|
|
134 |
C |
p.
|
artikel
|
| 185 |
Genetic analysis in primary dystonia: a prevalence study in patients followed up to Gemelli Hospital in Rome
|
Busco, V.
|
|
|
134 |
C |
p.
|
artikel
|
| 186 |
Genetic architecture of 230 Indian Parkinson's disease patients from a single centre
|
Kamath, S.D.
|
|
|
134 |
C |
p.
|
artikel
|
| 187 |
GLP-1 Receptor Agonists for Parkinson’s Disease: An Updated Meta-Analysis
|
Albuquerque, M.B.
|
|
|
134 |
C |
p.
|
artikel
|
| 188 |
GT-02287, a clinical-stage allosteric GCase modulator for the treatment of Parkinson’s disease, protects dopaminergic neurons against mitochondrial toxin MPP+
|
Pérez-Carmona, N.
|
|
|
134 |
C |
p.
|
artikel
|
| 189 |
Gut Microbiota and Parkinson’s Disease: Insights into the Gut-Brain Axis( A comprehensive review)
|
Rohan, K.
|
|
|
134 |
C |
p.
|
artikel
|
| 190 |
Harnessing Neuron-Specific Mechanisms of Autophagy as a Novel Therapeutic Intervention for Parkinson disease
|
Farah, M.J.
|
|
|
134 |
C |
p.
|
artikel
|
| 191 |
Head tremor: the intersection of ambiguities in the classification and pathophysiology of essential tremor
|
Ruzicka, E.
|
|
|
134 |
C |
p.
|
artikel
|
| 192 |
Hemimyoclonia Due to Rheumatic Pachymeningitis: A Case Report
|
Konuk, B.
|
|
|
134 |
C |
p.
|
artikel
|
| 193 |
Home-based portable transcranial direct current stimulation for mobility of individuals with complicated Parkinson’s disease
|
Hong, J.
|
|
|
134 |
C |
p.
|
artikel
|
| 194 |
Hormone Therapy and Parkinson’s Disease: A Case-Control Study
|
Tsutsumi, K.
|
|
|
134 |
C |
p.
|
artikel
|
| 195 |
Hybrid Treatment with the DopApp Digital Application Significantly Improved UPDRS in Levodopa-Treated Parkinson's Patients in a Double-Blind, Placebo-Controlled Trial
|
Oren, S.
|
|
|
134 |
C |
p.
|
artikel
|
| 196 |
Hypocalcaemia-induced fluctuating chorea in a patient with iatrogenic hypoparathyroidism: a case report
|
Mazzeo, F.P.
|
|
|
134 |
C |
p.
|
artikel
|
| 197 |
IAPRD Consensus Classification of Myoclonus
|
Latorre, A.
|
|
|
134 |
C |
p.
|
artikel
|
| 198 |
Identifying impulsivity problems in Parkinson’s disease: Corticomotor excitability and muscle bursting dynamics as markers of impaired impulse control
|
Warden, A.C.M.
|
|
|
134 |
C |
p.
|
artikel
|
| 199 |
Impact of 24-hour Subcutaneous Levodopa/Carbidopa Infusion (ND0612) on Daily Motor State Characteristics of Patients With PD Experiencing Motor Fluctuations
|
Ellenbogen, A.
|
|
|
134 |
C |
p.
|
artikel
|
| 200 |
Impact of IPX203 (CREXONT®) on Parkinson’s patients’ motor states upon awakening: analysis of patient diary data
|
Isaacson, S.H.
|
|
|
134 |
C |
p.
|
artikel
|
| 201 |
Impact of STN-DBS on Kinesthetic Illusion Processing in Parkinson’s Disease: An fMRI Study
|
Vijayakumari, A.A.
|
|
|
134 |
C |
p.
|
artikel
|
| 202 |
Impaired Cerebral Autoregulation in Parkinson’s Disease: A Disconnect Between Blood Pressure and Brain Perfusion
|
Thames, B.H.
|
|
|
134 |
C |
p.
|
artikel
|
| 203 |
Implementing Whole Gene Sequencing and Genetic Counseling Internationally for People with Parkinson’s Disease: The PD GENEration Experience
|
Galvelis, K.G.
|
|
|
134 |
C |
p.
|
artikel
|
| 204 |
Improvement in morning akinesia after foslevodopa/foscarbidopa treatment was associated with significantly improved motor fluctuations, activities of daily living, and quality
|
Pahwa, R.
|
|
|
134 |
C |
p.
|
artikel
|
| 205 |
Improvement in uninterrupted GOOD ON-time and reduction in OFF episodes with CSAI treatment
|
Kremens, D.
|
|
|
134 |
C |
p.
|
artikel
|
| 206 |
Improvement of depression and motor parameters after application of transcranial direct current stimulation in Parkinson’s disease
|
Kwon, D.Y.
|
|
|
134 |
C |
p.
|
artikel
|
| 207 |
Infantile-onset choreo-dystonia due to a novel homozygous truncating HPCA variant: A first report from India
|
Holla, Vikram V.
|
|
|
134 |
C |
p.
|
artikel
|
| 208 |
Influence of socioeconomic level on the progression and severity of Parkinson's disease
|
Álvarez-Hernández, C.F.
|
|
|
134 |
C |
p.
|
artikel
|
| 209 |
Influence of Toxic Exposure on the Age of Onset of Parkinson's Disease: An Observational and Analytical Study.
|
Martin-Mafud, G.A.
|
|
|
134 |
C |
p.
|
artikel
|
| 210 |
Influence of Trunk Range of Motion on Functional Mobility Outcome in Patients with Parkinson’s Disease: A scoping review
|
Romero-Maysonet, L.
|
|
|
134 |
C |
p.
|
artikel
|
| 211 |
Initiation of apomorphine hydrochloride injection (Apokyn) in the absence of an antiemetic in people with Parkinson disease
|
Happel, C.
|
|
|
134 |
C |
p.
|
artikel
|
| 212 |
Insulin-Degrading Enzyme (IDE) Regulates the Balance Between Soluble and Insoluble Alpha-Synuclein
|
Wu, Y.
|
|
|
134 |
C |
p.
|
artikel
|
| 213 |
Integrating Geolocation, Clinical Data and Social Determinants of Health in Parkinson’s Disease Management: Insights from Southwestern Colombia
|
Orozco, J.
|
|
|
134 |
C |
p.
|
artikel
|
| 214 |
Interpretation of MDS-UPDRS-III tremor measurements: a comparative study using accelerometry and patients scores
|
Smid, A.
|
|
|
134 |
C |
p.
|
artikel
|
| 215 |
Introducing Virtual Shared Medical Appointments as a Novel Treatment Platform for Functional Movement Disorders
|
Yu, X.X.
|
|
|
134 |
C |
p.
|
artikel
|
| 216 |
Introduction of Electrophysiologic Mapping For Refractory Cervical Dystonia in Ireland
|
Tse, T.
|
|
|
134 |
C |
p.
|
artikel
|
| 217 |
Investigating the impact of a short term dynamic neuromuscular stabilization and big movement training on balance in people with Parkinson’s.
|
Li, M.C.
|
|
|
134 |
C |
p.
|
artikel
|
| 218 |
Investigating the neuroprotective effects of betulinic acid: modulation of ferroptosis and apoptosis in Parkinson's disease
|
Pandey, S.K.
|
|
|
134 |
C |
p.
|
artikel
|
| 219 |
Investigating the role of virtual shared medical appointments in functional movement disorder care: Survey study insights
|
Zelinsky, M.
|
|
|
134 |
C |
p.
|
artikel
|
| 220 |
Investigation of Long Non-coding (lnc)-RNA expression profiles in patients with Parkinson’s Disease post-Rehabilitation treatment
|
La Rosa, F.
|
|
|
134 |
C |
p.
|
artikel
|
| 221 |
Is the Motor Reserve always a protective factor in movement disorders?
|
Castagna, A.
|
|
|
134 |
C |
p.
|
artikel
|
| 222 |
Is this really essential tremor?
|
Ziękiewicz, M.
|
|
|
134 |
C |
p.
|
artikel
|
| 223 |
KMT2B-related generalized dystonia: a case series and literature review, including a new pathogenic variant responsive to dbs
|
Romero Armenta, R.N.
|
|
|
134 |
C |
p.
|
artikel
|
| 224 |
Lack of association between G6PD and Parkinson's disease
|
Chifamba, L.V.
|
|
|
134 |
C |
p.
|
artikel
|
| 225 |
Lessons Learned from the ADAPT-PD Clinical Trial: Programming adaptive deep brain stimulation in the clinic
|
Herrington, T.M.
|
|
|
134 |
C |
p.
|
artikel
|
| 226 |
Leveraging Telehealth and Wearables for Parkinson’s Disease: Innovative Approaches to Enhance Personalized Care
|
Long, K.
|
|
|
134 |
C |
p.
|
artikel
|
| 227 |
Levodopa–entacapone–carbidopa intestinal gel (LECIG) in advanced Parkinson’s disease: a single center two-year experience
|
Szász, J.A.
|
|
|
134 |
C |
p.
|
artikel
|
| 228 |
Levosulpiride - a prokinetic agent that speeds up the gut but slows the body!
|
Pandey, B.
|
|
|
134 |
C |
p.
|
artikel
|
| 229 |
Lewy Body Pathology and Seeding-Competent Alpha-Synuclein Alone Do Not Drive Molecular or Cellular Changes in Dopaminergic Neurons
|
Rumpf, S.L.
|
|
|
134 |
C |
p.
|
artikel
|
| 230 |
Linking motor and non-motor manifestations in de novo Parkinson’s disease: A cross-sectional study
|
Kwon, K.Y.
|
|
|
134 |
C |
p.
|
artikel
|
| 231 |
Long-Duration Levodopa Response in Parkinson's Disease: Insights from the PPMI Cohort
|
Schnalke, N.
|
|
|
134 |
C |
p.
|
artikel
|
| 232 |
Longitudinal MRI Assessment of Brain Changes in Parkinson’s Disease
|
Kozlowski, E.
|
|
|
134 |
C |
p.
|
artikel
|
| 233 |
LONG-NEXT: A new accurate and efficient NGS-based method for GBA1 analysis in Parkinson disease
|
Cuconato, Giada
|
|
|
134 |
C |
p.
|
artikel
|
| 234 |
Long term evaluation of gluten-free diet on motor functions, cognition and metabolomics in Parkinson ́s disease patients
|
Brozova, H.
|
|
|
134 |
C |
p.
|
artikel
|
| 235 |
Long-term safety and tolerability of levodopa–entacapone–carbidopa intestinal infusion in advanced Parkinson’s disease – interim results from the ELEGANCE study
|
Dulamea, A.O.
|
|
|
134 |
C |
p.
|
artikel
|
| 236 |
Loss of Fragile X Mental Retardation Protein (FMRP) Alters Striatal Dopamine Transporter Surface Enrichment and Dopamine Turnover
|
Gao, P.
|
|
|
134 |
C |
p.
|
artikel
|
| 237 |
Lysosomal dysfunction genetics and biomarkers in de novo Parkinson’s disease
|
Enriquez, S.
|
|
|
134 |
C |
p.
|
artikel
|
| 238 |
Machine Learning approaches for predicting Levodopa-Induced Dyskinesias in Latino Populations
|
Chaparro-Solano, H.M.
|
|
|
134 |
C |
p.
|
artikel
|
| 239 |
Magnetic Resonance Imaging Combined with Advanced Data Models for Detection of Parkinson’s Disease: A scoping review.
|
Ali, M.A.
|
|
|
134 |
C |
p.
|
artikel
|
| 240 |
Malignant Neuroleptic Syndrome in a Patient with Huntington's Disease
|
Ziękiewicz, M.
|
|
|
134 |
C |
p.
|
artikel
|
| 241 |
Malignant Neuroleptic Syndrome in a Patient with Huntington's Disease
|
Ziękiewicz, M.
|
|
|
134 |
C |
p.
|
artikel
|
| 242 |
Medication Effects on Bradykinesia, Tremor, Gait and Balance in Parkinson's Disease, Measured by Wearable Sensors
|
Weijer, R.H.A.
|
|
|
134 |
C |
p.
|
artikel
|
| 243 |
Metabolic brain networks in prodromal dementia with Lewy bodies and prodromal dementia due to Alzheimer disease
|
Perovnik, M.
|
|
|
134 |
C |
p.
|
artikel
|
| 244 |
Microbial diversity in drug naïve Parkinson's disease patients in Croatia
|
Papić, E.
|
|
|
134 |
C |
p.
|
artikel
|
| 245 |
Microelectrode investigation of pallidal activity in Parkinson’s disease patients with focal dystonia
|
Pavlovsky, P.
|
|
|
134 |
C |
p.
|
artikel
|
| 246 |
Mitochondrial and autophagic dysfunctions of skin fibroblasts derived from pantothenate kinase-associated neurodegeneration patients carrying PANK2 mutations and the rescuing effects of allantoin
|
Zhu, Junge
|
|
|
134 |
C |
p.
|
artikel
|
| 247 |
Mitochondrial impairments in mononuclear cells are associated with inflammation in Parkinson’s disease.
|
Afaar, F.
|
|
|
134 |
C |
p.
|
artikel
|
| 248 |
Mitochondrial Membrane Protein-Associated Neurodegeneration (MPAN) Presenting With Parkinsonism Findings: A Case Report
|
Hasdemİr, İ.
|
|
|
134 |
C |
p.
|
artikel
|
| 249 |
Mixed brain pathology in neurodegenerative parkinsonism and dementia
|
Mensikova, K.
|
|
|
134 |
C |
p.
|
artikel
|
| 250 |
MOBP gene risk variant is associated with higher cerebrospinal fluid levels of neurofilament light chain: a Barcelona PSP Registry study
|
Compta, Y.
|
|
|
134 |
C |
p.
|
artikel
|
| 251 |
Modeling Dementia in Patients with Parkinson’s Disease Years After Deep Brain Stimulation Surgery
|
Gunawardena, S.
|
|
|
134 |
C |
p.
|
artikel
|
| 252 |
Moderators of aerobic exercise effects on motor symptoms in patients with Parkinson's disease: A systematic review and meta-analysis
|
Kim, Ryul
|
|
|
134 |
C |
p.
|
artikel
|
| 253 |
"Modulation of Reward Processing in Parkinson's Disease: Insights from Pupillometry and Dopaminergic Medication Effects on Neuropsychiatric Symptoms"
|
Sasikumar Bhuvaneswari, K.
|
|
|
134 |
C |
p.
|
artikel
|
| 254 |
Monitoring Parkinson’s Progression: Eye Movements vs. MDS-UPDRS III
|
Gurevich, T.
|
|
|
134 |
C |
p.
|
artikel
|
| 255 |
Montelukast protects against MPTP-induced ferroptosis by suppressing 5-lipoxygenase: Implication for Parkinson’s disease
|
Oh, E.
|
|
|
134 |
C |
p.
|
artikel
|
| 256 |
Morphological Correlates of Freezing of Gait in Parkinson’s Disease
|
Chen, J.
|
|
|
134 |
C |
p.
|
artikel
|
| 257 |
Mortality in elderly Parkinson’s disease patients with long-term care needs: A nationwide population-based study in Korea
|
Lee, S.H.
|
|
|
134 |
C |
p.
|
artikel
|
| 258 |
Motivational disturbances and cognitive effort-based decision-making in Parkinson's disease
|
Scott, Bonnie M.
|
|
|
134 |
C |
p.
|
artikel
|
| 259 |
Motivation Matters: Elucidating factors driving exercise in people with Parkinson’s Disease
|
Cools, C.I.
|
|
|
134 |
C |
p.
|
artikel
|
| 260 |
Movement Disorders in Alcoholics: Diagnostic Dilemmas & Therapeutic Insights
|
Hirani, P.
|
|
|
134 |
C |
p.
|
artikel
|
| 261 |
MR-Guided Focused Ultrasound for Essential Tremor and Parkinson’s Disease: Update on Current State and Ongoing Trials
|
Gant, K.
|
|
|
134 |
C |
p.
|
artikel
|
| 262 |
Multidisciplinary Treatment of Tremor and Migraine: A Clinical Study on Efficacy and Outcomes
|
Akbarkhodjaeva, Z.A.
|
|
|
134 |
C |
p.
|
artikel
|
| 263 |
Multimodal Brain Imaging Combined with Advanced Data Models for Detection of Prodromal Parkinson’s Disease: A Scoping Review
|
Serag, I.
|
|
|
134 |
C |
p.
|
artikel
|
| 264 |
Mutational analysis of TFAM gene and analysis of oxidative stress among Parkinson's disease (PD) patients from Punjab Population, INDIA
|
Iyer, M.
|
|
|
134 |
C |
p.
|
artikel
|
| 265 |
Mutations in the PDE10A gene: report of two siblings with a novel variant and a review of the literature
|
Tacik, P.
|
|
|
134 |
C |
p.
|
artikel
|
| 266 |
Neural Correlates of Freezing of Gait: Role of Cortical Myelination in Parkinson's Disease
|
Rathi, G.N.
|
|
|
134 |
C |
p.
|
artikel
|
| 267 |
Neurocognition, Cerebellar Functions and Psychiatric Features in Spinocerebellar Ataxia Type 34
|
Cundari, M.
|
|
|
134 |
C |
p.
|
artikel
|
| 268 |
Neuroinflammation in Parkinson’s Disease: Insights from CSF Cytokines and Chemokines
|
Krishnan, K.V.
|
|
|
134 |
C |
p.
|
artikel
|
| 269 |
Neuromelanin and Parkinson’s Disease: A Comprehensive imaging biomarker and a early diagnostic tool
|
Krishnan, K.V.
|
|
|
134 |
C |
p.
|
artikel
|
| 270 |
Neuroprotective effect of BITC as a new therapeutical approach for the management of Parkinson’s Disease
|
Lanza, M.
|
|
|
134 |
C |
p.
|
artikel
|
| 271 |
Neuroprotective Effects of the Epigenetic Modulator Decitabine in 6-OHDA-Induced Cellular and Mouse Models of Parkinson's Disease
|
Kumari, S.
|
|
|
134 |
C |
p.
|
artikel
|
| 272 |
Neuropsychological studies in children with tic hyperkinesis
|
Maxamatjanova, N.M.
|
|
|
134 |
C |
p.
|
artikel
|
| 273 |
Neurotrophic dysregulation in a castration base model of PD
|
Kudriavetz, S.C.
|
|
|
134 |
C |
p.
|
artikel
|
| 274 |
New insights into Parkinson’s treatment: GIT27’s role in modulating TLR4
|
Cucinotta, L.
|
|
|
134 |
C |
p.
|
artikel
|
| 275 |
New Onset Parkinson’s Disease Psychosis after use of “Horny Goat Weed” Supplement
|
Deliz, J.R.
|
|
|
134 |
C |
p.
|
artikel
|
| 276 |
Nonmotor symptoms in Parkinson's disease patients in South Asia: A systematic review and meta-analysis
|
Paudel, P.
|
|
|
134 |
C |
p.
|
artikel
|
| 277 |
Non-oscillatory properties of pallidal single unit activity in parkinsonian patients with tremor
|
Sedov, A.
|
|
|
134 |
C |
p.
|
artikel
|
| 278 |
Non Stiff Anti-Amphiphysin Syndrome: A Case Report
|
Doğan Yelkenci, C.
|
|
|
134 |
C |
p.
|
artikel
|
| 279 |
Novel Deep Learning Models for Automatic Assessment of Motor Disease Severity in Parkinson’s Disease
|
Chakraborty, I.
|
|
|
134 |
C |
p.
|
artikel
|
| 280 |
Novel Findings on CCR1 Receptor: A Pathogenic Marker Useful in Controlling Neuroimmune and Neuroinflammatory Mechanisms in Parkinson’s Disease
|
Ardizzone, A.
|
|
|
134 |
C |
p.
|
artikel
|
| 281 |
Novel Genetic Loci Affecting Age at Onset of Parkinson’s Disease: A Genome-wide Association Study
|
Hwang, Y.S.
|
|
|
134 |
C |
p.
|
artikel
|
| 282 |
Novel KIF5A Mutation Identified in a Romani Kindred with Familial Dystonia
|
Dulski, J.
|
|
|
134 |
C |
p.
|
artikel
|
| 283 |
Novel RAB39B variant in Parkinson’s Disease with unusual radiological findings: a Case Report
|
Gallo, L.
|
|
|
134 |
C |
p.
|
artikel
|
| 284 |
Omega-3 Fatty Acids: A Lifelong Ally in Preventing Parkinson’s Disease
|
Krishnan, K.V.
|
|
|
134 |
C |
p.
|
artikel
|
| 285 |
On demand inhaled levodopa in Parkinson´s disease (pd) patients with device assisted therapies
|
Morales-Casado, M.I.
|
|
|
134 |
C |
p.
|
artikel
|
| 286 |
Online unsupervised performance-based cognitive testing: A feasible and reliable approach to scalable cognitive phenotyping of Parkinson's patients
|
Balit, N.
|
|
|
134 |
C |
p.
|
artikel
|
| 287 |
Opicapone as First-Line Strategy for the Treatment of Wearing-off in Patients with Parkinson's Disease
|
Ferreira, J.J.
|
|
|
134 |
C |
p.
|
artikel
|
| 288 |
Opicapone improved Parkinson’s disease-related sleep disturbances: Findings from the OASIS study
|
Ferreira, J.
|
|
|
134 |
C |
p.
|
artikel
|
| 289 |
Optical illusions and visuo-cognition in individuals with isolated REM sleep behavior disorder
|
Johannes, P.
|
|
|
134 |
C |
p.
|
artikel
|
| 290 |
Orthostatic Hypotension: Prevalence and Disease Dynamics
|
Ovchynnykova, A.
|
|
|
134 |
C |
p.
|
artikel
|
| 291 |
Outcomes following initiation of amantadine DR/ER (Gocovri) in patients with Parkinson disease - evaluation of the AAN Axon registry database
|
Grall, M.
|
|
|
134 |
C |
p.
|
artikel
|
| 292 |
Outcomes of Acute Agitation Treatment in Hospitalized Patients with Parkinsonism: Intravenous Benzodiazepines versus Parenteral Antipsychotics
|
Kundrick, A.
|
|
|
134 |
C |
p.
|
artikel
|
| 293 |
Outcomes of the Parkinson’s Foundation Hospital Care Learning Collaborative: Expanding the use of Electronic Health Record Interventions across 22 hospitals
|
Brooks, A.
|
|
|
134 |
C |
p.
|
artikel
|
| 294 |
Pain in Parkinson’s disease: Prevalence, severity and related factors
|
Etoom, M.
|
|
|
134 |
C |
p.
|
artikel
|
| 295 |
Parkinson in Balance: an online self-management program for people with Parkinson's Disease
|
Duits, A.A.
|
|
|
134 |
C |
p.
|
artikel
|
| 296 |
Parkinsonism and Neuroprotection in Bodybuilding
|
Zaynutdinov, M.
|
|
|
134 |
C |
p.
|
artikel
|
| 297 |
Parkinsonism with Nigrostriatal Degeneration in Early Huntington’s Disease
|
Ipavic, E.
|
|
|
134 |
C |
p.
|
artikel
|
| 298 |
Parkinson's Disease and Cancer: A Meta-Analysis of Prevalence, Risk, and Specific Associations with Brain and Skin Cancers
|
Khelifa, H.
|
|
|
134 |
C |
p.
|
artikel
|
| 299 |
Parkinson’s disease and neuroprotective therapy: Prospects of stem cells and gene therapy
|
Yuldasheva, N.B.
|
|
|
134 |
C |
p.
|
artikel
|
| 300 |
Parkinson’s Disease and Parkinsonism Family Center: A Pezzoli Foundation’s Psychoeducational Program for Patients, Families and Caregivers
|
Serini, M.
|
|
|
134 |
C |
p.
|
artikel
|
| 301 |
Parkinson's disease: fear of fall, slow cadence; efficacy of spinal extensors strengthening exercise
|
Mandal, R.
|
|
|
134 |
C |
p.
|
artikel
|
| 302 |
Parkinson’s disease genetic risk variants are associated with larger intracranial and subcortical structure volumes in healthy and high-risk individuals
|
Lin, A.
|
|
|
134 |
C |
p.
|
artikel
|
| 303 |
Patient Experiences Initiating Continuous Subcutaneous Apomorphine Infusion (CSAI): An Interview-Based Survey of InfusON Study Participants
|
Agarwal, P.
|
|
|
134 |
C |
p.
|
artikel
|
| 304 |
Patients with dysphagia have multiple options for taking once-daily valbenazine to treat tardive dyskinesia or chorea associated with Huntington’s disease
|
Jimenez, R.
|
|
|
134 |
C |
p.
|
artikel
|
| 305 |
PD GENEration: A Cross-sectional Evaluation of Cognitive Complaints in Parkinson’s Disease (PD) Patients According to GBA1 and DBS Status
|
Son, J.
|
|
|
134 |
C |
p.
|
artikel
|
| 306 |
People with Huntington's disease showed deterioration in clinically administered disease-related measures but not in self-reported ones over 12 months.
|
Wani, D.
|
|
|
134 |
C |
p.
|
artikel
|
| 307 |
Perioperative quantification of MDS-UPDRS-III tremor measurements in patients with Parkinson’s Disease using accelerometry
|
Smid, A.
|
|
|
134 |
C |
p.
|
artikel
|
| 308 |
Pharmacokinetic-Pharmacodynamic Modeling of Amantadine Extended-Release Capsule Effects on Dyskinesia in Parkinson Disease
|
Wang, Z.
|
|
|
134 |
C |
p.
|
artikel
|
| 309 |
Practical Tools to Improve the Implementation of Expiratory Muscle Strength Training via Telehealth
|
Veit, K.R.
|
|
|
134 |
C |
p.
|
artikel
|
| 310 |
Predicting Time-to-Phenoconversion to Parkinson’s Disease/Dementia with Lewy Bodies in Idiopathic REM Sleep Behavior Disorder (iRBD) Using Machine Learning
|
Fereshtehnejad, S.M.
|
|
|
134 |
C |
p.
|
artikel
|
| 311 |
Prevalence of dysphagia among patients with Huntington’s disease: a literature review
|
Amjad, F.
|
|
|
134 |
C |
p.
|
artikel
|
| 312 |
Prevalence of peri-electrode edema and intraparenchymal cyst formation as a complication of Deep Brain Stimulation surgery: A systematic review
|
Prado Miranda, G.
|
|
|
134 |
C |
p.
|
artikel
|
| 313 |
Preventing Contraindicated Medications in Hospitalized People with Parkinson’s Disease: A Year-Long Optimized Proactive Intervention
|
Piccinin, C.C.
|
|
|
134 |
C |
p.
|
artikel
|
| 314 |
Profiling of Aggregation-Prone Motifs in Alpha-Synuclein and Implication for Targeted Therapeutic Development
|
Shah, S.
|
|
|
134 |
C |
p.
|
artikel
|
| 315 |
Progressive supranuclear palsy in a patient with lipoma of the corpus callosum
|
Ziękiewicz, M.
|
|
|
134 |
C |
p.
|
artikel
|
| 316 |
Progress on Virtual Reality in Reducing Fear of Falling in Parkinson's Disease Rehabilitation
|
Bao, Y.
|
|
|
134 |
C |
p.
|
artikel
|
| 317 |
Prospective Quantitative Evaluation of Brain Iron Accumulation in Parkinson's Disease Patients Compared to REM Sleep Behavior Disorder Patients and Healthy
|
Shtilbans, A.
|
|
|
134 |
C |
p.
|
artikel
|
| 318 |
Protective Lifestyle Risk Factors Against Parkinson’s Disease In Sub-Saharan Africa: A Review On Current Evidence
|
Napoleon, O.
|
|
|
134 |
C |
p.
|
artikel
|
| 319 |
Quality of Life, Depression, and Lived Experiences of Women with Parkinson’s Disease after Deep Brain Stimulation: A mixed-methods study
|
Kim, M.S.
|
|
|
134 |
C |
p.
|
artikel
|
| 320 |
Quality of life of patients with Parkinson’s disease in the central belt of ghana
|
Obese, V.
|
|
|
134 |
C |
p.
|
artikel
|
| 321 |
Quantitative corneal nerve beading analysis: A novel biomarker for Parkinson's disease progression
|
Yaisawang, Sasi
|
|
|
134 |
C |
p.
|
artikel
|
| 322 |
Randomised controlled trial testing clinical and cost-effectiveness of the Live Well self-management toolkit for people with Parkinson’s and their carers
|
Schrag, A.
|
|
|
134 |
C |
p.
|
artikel
|
| 323 |
Rare cause of late-onset multifocal dystonia
|
Tacik, P.
|
|
|
134 |
C |
p.
|
artikel
|
| 324 |
Rationale for LRRK2 inhibition in sporadic Parkinson’s disease and the LUMA trial
|
Hauser, R.A.
|
|
|
134 |
C |
p.
|
artikel
|
| 325 |
Real world evidence of efficacy ad safety of subcutaneus foslevodopa/foscarbidopa infusion in advanced Parkinson disease
|
Morales-Casado, M.I.
|
|
|
134 |
C |
p.
|
artikel
|
| 326 |
Real World Impact of Subcutaneous Levodopa Infusion in Advanced Parkinson’s Disease after Six Months: A Tertiary Center Experience
|
Rački, V.
|
|
|
134 |
C |
p.
|
artikel
|
| 327 |
Rebalance of mitophagy by inhibiting LRRK2 improves colon alterations in an MPTP in vivo model
|
Campolo, M.
|
|
|
134 |
C |
p.
|
artikel
|
| 328 |
Recommendations for a paradigm shift in approach to increase the recognition and treatment of sialorrhea in Parkinson’s disease
|
Bergmans, B.
|
|
|
134 |
C |
p.
|
artikel
|
| 329 |
REEP1 gene mutation associated with Hereditary Spastic Paraplegia type 31 and Parkinsonism
|
Doğan Yelkenci, C.
|
|
|
134 |
C |
p.
|
artikel
|
| 330 |
Relationship Between Dysphagia, Brainstem and Cortical Volumes in Parkinson's Disease
|
Sahin, E.
|
|
|
134 |
C |
p.
|
artikel
|
| 331 |
Reliability of Remote Video Ratings of the Scale for Assessment and Rating of Ataxia
|
Vizcarra, J.A.
|
|
|
134 |
C |
p.
|
artikel
|
| 332 |
REM density in Parkinson’s disease: Effects of motor, cognitive, and autonomic function, and the impact of evening dopaminergic medication
|
Dagay, A.
|
|
|
134 |
C |
p.
|
artikel
|
| 333 |
Remission of Tardive Dyskinesia in Patients Receiving Long-Term Valbenazine Treatment
|
Bahroo, L.
|
|
|
134 |
C |
p.
|
artikel
|
| 334 |
Response -- letter to the editor: Unraveling the neural signatures: Distinct pallidal patterns in dystonia subtypes
|
Shaikh, Aasef G.
|
|
|
134 |
C |
p.
|
artikel
|
| 335 |
Restless legs syndrome in stroke: case-control study
|
Falup-Pecurariu, C.
|
|
|
134 |
C |
p.
|
artikel
|
| 336 |
Restless legs syndrome in traumatic brain injury
|
Falup-Pecurariu, C.
|
|
|
134 |
C |
p.
|
artikel
|
| 337 |
RFC1 repeat expansions as a potential cause of "atypical" atypical parkinsonism
|
Oggiano, F.
|
|
|
134 |
C |
p.
|
artikel
|
| 338 |
Role of m6A-Modified CXCR4 in Regulating the FAK/Src Signaling Pathway in Parkinson’s Disease
|
Zeng, S.
|
|
|
134 |
C |
p.
|
artikel
|
| 339 |
Role of RNA-Binding Protein PCBP1 in Regulating Selective Splicing of E3 Ubiquitin Ligase WWP2 in Parkinson’s Disease
|
Yusufujiang, A.
|
|
|
134 |
C |
p.
|
artikel
|
| 340 |
Role of the cytokine eNAMPT in controlling neuroinflammation in Parkinson Diseases
|
Paterniti, I.
|
|
|
134 |
C |
p.
|
artikel
|
| 341 |
Safety and Efficacy of a Wrist-Worn Vibratory Wearable for Upper Limb Tremor Reduction in ET (ULTRE): A Randomized, Controlled Trial
|
Nahab, F.B.
|
|
|
134 |
C |
p.
|
artikel
|
| 342 |
Safety of Adipose-Derived Stromal Vascular Fraction Cells to Treat Parkinson's Disease
|
Carstens, M.H.
|
|
|
134 |
C |
p.
|
artikel
|
| 343 |
Safety, tolerability, and clinical assessment of bemdaneprocel for Parkinson’s disease: Results through 24 months from a Phase 1 study
|
Henchcliffe, C.
|
|
|
134 |
C |
p.
|
artikel
|
| 344 |
Safety, tolerability, and efficacy of intracranial delivery of autologous iPSC-derived dopaminergic precursors in moderate to advanced Parkinson’s Disease
|
Fraint, A.
|
|
|
134 |
C |
p.
|
artikel
|
| 345 |
Screening for exercise intolerance in Parkinson’s Disease and related disorders: a holistic assessment
|
Weinstock, B.
|
|
|
134 |
C |
p.
|
artikel
|
| 346 |
Secondary dementia and parkinsonism due to chronic Lyme neuroborreliosis
|
Sarac, I.
|
|
|
134 |
C |
p.
|
artikel
|
| 347 |
Secondary dysautonomia due to pituitary adenoma in a patient with Parkinson’s disease
|
Busco, V.
|
|
|
134 |
C |
p.
|
artikel
|
| 348 |
Secondary treatment failure with abobotulinumtoxinA, incobotulinumtoxinA and onabotulinumtoxinA: A systematic review and meta-analysis
|
Walter, U.
|
|
|
134 |
C |
p.
|
artikel
|
| 349 |
Segmental Dystonia with hearing loss
|
Das, A.
|
|
|
134 |
C |
p.
|
artikel
|
| 350 |
Self-Perception of Exercise Level and Its Role in Physical Activity Engagement in People with Early-Stage Parkinson Disease
|
Pacheco, A.
|
|
|
134 |
C |
p.
|
artikel
|
| 351 |
Self-reported physical activity and functional capacity outcomes in people with Huntington’s Disease.
|
Bjalme-Evans, M.
|
|
|
134 |
C |
p.
|
artikel
|
| 352 |
Sex differences in the diagnosis latency of Parkinson's disease in Latin America
|
Ramchandra, Janvi
|
|
|
134 |
C |
p.
|
artikel
|
| 353 |
Sex Differences in the Sensorimotor Cough Function of Individuals with Parkinson’s Disease
|
Dallal-York, J.
|
|
|
134 |
C |
p.
|
artikel
|
| 354 |
Significant Improvements in Motor and Non-Motor symptoms with Corresponding Neuroimaging Changes Following Hybrid Levodopa-Digital Application Treatment in Parkinson's Patients
|
Amedi, A.
|
|
|
134 |
C |
p.
|
artikel
|
| 355 |
Skin and Gut Microbiome Profiles as Potential Biomarkers in Parkinson’s Disease: Preliminary Results
|
Kasprzak, J.
|
|
|
134 |
C |
p.
|
artikel
|
| 356 |
Skin test to detect Parkinson's and related disorders
|
Srikaran,
|
|
|
134 |
C |
p.
|
artikel
|
| 357 |
Sociocultural Factors and Other Determinants of Cognitive Impairment in People Living with Parkinson's Disease
|
Ulloa-Hernández, D.
|
|
|
134 |
C |
p.
|
artikel
|
| 358 |
Spinocerebellar Ataxia Type 28 (SCA28) with Hypertrophic Olivary Degeneration: A Case Report and Exploration of Potential Pathophysiological Overlap
|
Tar, M.
|
|
|
134 |
C |
p.
|
artikel
|
| 359 |
Staged, bilateral MR-guided focused ultrasound of the pallidothalamic tract in Parkinson’s disease: a phase III study
|
Sarva, H.
|
|
|
134 |
C |
p.
|
artikel
|
| 360 |
STUB1-Related Dystonia: Expanding the Phenotype and First Evidence of DBS-GPi Efficacy
|
Kasprzak, J.
|
|
|
134 |
C |
p.
|
artikel
|
| 361 |
Study of the Incidence and Prevalence of Depression after Parkinson's disease, Ischemic stroke, and Migraine in the population of Uzbekistan
|
Qarshiboyeva, N.
|
|
|
134 |
C |
p.
|
artikel
|
| 362 |
Subjective cognitive decline in individuals with isolated REM sleep behavior disorder: Characterization, neuropsychological correlates, and structural brain changes
|
Ophey, A.
|
|
|
134 |
C |
p.
|
artikel
|
| 363 |
Subjective Patient Rating as a Novel Feedback Signal for DBS Programming in Parkinson’s Disease
|
Dong, J.
|
|
|
134 |
C |
p.
|
artikel
|
| 364 |
Subjective Patient Rating Suggests an Alternative Sweet Spot for DBS Programming in Essential Tremor
|
Peschke, S.
|
|
|
134 |
C |
p.
|
artikel
|
| 365 |
Successful rescue of severe cervical dystonia by electrophysiologic mapping to optimize botulinum neurotoxin treatment in Ireland
|
Tse, T.
|
|
|
134 |
C |
p.
|
artikel
|
| 366 |
Surface electromyography as an objective marker for deep brain stimulation programming.
|
Wang, A.
|
|
|
134 |
C |
p.
|
artikel
|
| 367 |
Sustained Benefit of the Wrist-Worn Vibratory Wearable in the Upper Limb Tremor Reduction in Essential Tremor (ULTRE)
|
Nahab, F.B.
|
|
|
134 |
C |
p.
|
artikel
|
| 368 |
Sustained chorea improvements with long-term, once-daily valbenazine in adults with Huntington’s disease
|
Furr Stimming, E.
|
|
|
134 |
C |
p.
|
artikel
|
| 369 |
Swallowing Difficulties and Hospital Care in Parkinson’s Disease: Preliminary Findings on Prevalence and Opportunities for Improvement
|
Piccinin, C.C.
|
|
|
134 |
C |
p.
|
artikel
|
| 370 |
Symptom changes with hormonal variations in genetic dystonia
|
Pullman, M.
|
|
|
134 |
C |
p.
|
artikel
|
| 371 |
Synthetic PGC-1α activator ameliorates the MPP+/MPTP-induced dopaminergic degeneration in Parkinson’s Disease via regulating PGC-1α-mediated mitochondrial homeostasis
|
Kaur, J.
|
|
|
134 |
C |
p.
|
artikel
|
| 372 |
Tau and ɑ-synucleinopathy co-pathology in military veterans with parkinsonism: an autopsy study
|
Flores Almazan, V.
|
|
|
134 |
C |
p.
|
artikel
|
| 373 |
Tau biomarkers for neurodegenerative diseases: Current state and perspectives
|
Vacchi, Elena
|
|
|
134 |
C |
p.
|
artikel
|
| 374 |
Tavapadon, an Orally Administered, Once-Daily, Selective D1/D5 Partial Dopamine Agonist for Adjunctive Treatment of Parkinson’s Disease With Motor Fluctuations
|
Fernandez, H.H.
|
|
|
134 |
C |
p.
|
artikel
|
| 375 |
Temporal Order Judgment (TOJ) in Parkinson’s disease
|
Akshaya, R.
|
|
|
134 |
C |
p.
|
artikel
|
| 376 |
The Affected Patients’ Perspective on Active Cohort Recruitment for Early, Prodromal Detection of alpha-Synucleinopathies
|
Röttgen, S.
|
|
|
134 |
C |
p.
|
artikel
|
| 377 |
The BEACON Study: LRRK2 inhibition by BIIB122/DNL151 in participants with Pathogenic LRRK2 Variants and Parkinson’s disease
|
Jennings, D.
|
|
|
134 |
C |
p.
|
artikel
|
| 378 |
The CARIPLO Parkinson’s disease cohort: phenotypic characterization of patients
|
Polverino, P.
|
|
|
134 |
C |
p.
|
artikel
|
| 379 |
The clinical relationship of cognitive impairment in Parkinson's disease
|
Rakhimbaeva, G.S.
|
|
|
134 |
C |
p.
|
artikel
|
| 380 |
The clinical spectrum and pathogenesis associated with KMT2B variants in Chinese pediatric patients
|
Ding, S.
|
|
|
134 |
C |
p.
|
artikel
|
| 381 |
The effect of dopaminergic medication on the haptic Aubert-Fleischl phenomenon in Parkinson's disease
|
Pipan, E.
|
|
|
134 |
C |
p.
|
artikel
|
| 382 |
The effect of rehabilitation therapy in Parkinsonism
|
Alimbekova, L.U.
|
|
|
134 |
C |
p.
|
artikel
|
| 383 |
The effects of stretching in Parkinson's disease: A systematic review of randomized controlled trials
|
Duñabeitia, Iratxe
|
|
|
134 |
C |
p.
|
artikel
|
| 384 |
The factors for choosing intesticular gel therapy
|
Kovacs, N.
|
|
|
134 |
C |
p.
|
artikel
|
| 385 |
The financial limitations of fixed budget deep brain stimulation treatment: Should we implant new patients or replace the old ones?
|
Kovacs, N.
|
|
|
134 |
C |
p.
|
artikel
|
| 386 |
The Impact of Autonomic Disorders in Parkinson's Disease and the Importance of Early Diagnosis
|
Tolibov, D.S.
|
|
|
134 |
C |
p.
|
artikel
|
| 387 |
The impact of bright light therapy on Parkinson's disease: A pilot study using vestibular-evoked myogenic potentials
|
Xie, Wei-ye
|
|
|
134 |
C |
p.
|
artikel
|
| 388 |
The impact of Parkinson’s Syndrome on Activities of Daily Living in Cerebrovascular Disease Patients with Metabolic Syndrome.
|
Tokhirova, M.S.
|
|
|
134 |
C |
p.
|
artikel
|
| 389 |
The Impact of Physical Activity on Neuroplasticity in Patients with Parkinson’s Disease
|
Xusanova, M.
|
|
|
134 |
C |
p.
|
artikel
|
| 390 |
The Impact of Skin Biopsy on the Management of Suspected Synucleinopathies: A Single-Center Real-World Experience
|
Anis, S.
|
|
|
134 |
C |
p.
|
artikel
|
| 391 |
The influence of fatigue on motor imagery ability in people with Parkinson’s disease – preliminary study
|
Tsai, Y.C.
|
|
|
134 |
C |
p.
|
artikel
|
| 392 |
The iNPH Radscale May Better Predict Whether Ventriculoperitonal Shunting was Offered, Compared to Drain Trial Gait Variables
|
Soehnlen, X.
|
|
|
134 |
C |
p.
|
artikel
|
| 393 |
The Interrelationship Between Pain, Mental Health, and Physical Activity in Parkinson's Disease: A Comparative Study with Healthy Controls
|
Al-Wardat, M.
|
|
|
134 |
C |
p.
|
artikel
|
| 394 |
The Movement Disorders Brain Bank at Columbia University: A Brief History and a Path Forward
|
Agin-Liebes, J.
|
|
|
134 |
C |
p.
|
artikel
|
| 395 |
The natural history of body-first versus brain-first Parkinson disease subtypes
|
Velucci, V.
|
|
|
134 |
C |
p.
|
artikel
|
| 396 |
Therapeutic strategies based on inflammation/immunotherapy
|
Tansey, M.G.
|
|
|
134 |
C |
p.
|
artikel
|
| 397 |
The relationship between sleep disorders and fibrinogen levels in Parkinson's plus syndromes: results of a scientific study
|
Akramova, D.
|
|
|
134 |
C |
p.
|
artikel
|
| 398 |
The Role of Antioxidant Therapy in Slowing the Progression of Parkinson’s Disease
|
Xusanova, M.
|
|
|
134 |
C |
p.
|
artikel
|
| 399 |
The role of gyroscope in the assessment of botulinum toxin treatment of dystonic head tremor
|
Santurelli, P.
|
|
|
134 |
C |
p.
|
artikel
|
| 400 |
The role of the monooxygenase system in the development of parkinsonism and the possibility of correction
|
Alimbekova, L.U.
|
|
|
134 |
C |
p.
|
artikel
|
| 401 |
The roles of Type 2 Diabetes Mellitus and caffeine intake in Parkinson's Disease risk.
|
Mallavarapu, K.
|
|
|
134 |
C |
p.
|
artikel
|
| 402 |
The syndrome of sustained shoulder elevation: a functional movement disorder
|
Albanese, A.
|
|
|
134 |
C |
p.
|
artikel
|
| 403 |
The Syn-D Study: Detection of Cutaneous Phosphorylated Alpha-Synuclein and blood P-Tau 217 in Patients with Mild Cognitive Impairment
|
Levine, T.
|
|
|
134 |
C |
p.
|
artikel
|
| 404 |
The Syn-One Test®: A Patient Perspectives Study
|
Mahant, P.
|
|
|
134 |
C |
p.
|
artikel
|
| 405 |
The third wheel or the game changer? How AI could team up with neurologists in Parkinson's care
|
Malaguti, Maria Chiara
|
|
|
134 |
C |
p.
|
artikel
|
| 406 |
Three dimensional mapping of nigrostriatal co-pathology using brain clearing: an autopsy study
|
Jere, M.
|
|
|
134 |
C |
p.
|
artikel
|
| 407 |
Time perception patterns in patients with Parkinson’s disease and Alzheimer’s disease
|
Chimagomedova, A.Sh.
|
|
|
134 |
C |
p.
|
artikel
|
| 408 |
Tiny Couriers, Profound Impact: Extracellular Vesicles in Parkinson’s Disease
|
Arulalan, S.
|
|
|
134 |
C |
p.
|
artikel
|
| 409 |
TMS-evoked potentials provide novel neurophysiological features of Tourette syndrome
|
Anis, S.
|
|
|
134 |
C |
p.
|
artikel
|
| 410 |
To determine the use of Transcranial sonography in differentiating Parkinsonism syndromes
|
Kammineni, A.
|
|
|
134 |
C |
p.
|
artikel
|
| 411 |
TOR1AIP2 as a candidate gene for dystonia-hemichorea/hemiballism
|
Kafantari, Efthymia
|
|
|
134 |
C |
p.
|
artikel
|
| 412 |
Towards a unified language for dance-based rehabilitation in neurological populations: A motor control framework bridging practice and research
|
Leung, S.
|
|
|
134 |
C |
p.
|
artikel
|
| 413 |
TRANQUIL: Pivotal study of the Felix NeuroAI Wristband in patients with essential tremor
|
Ondo, W.
|
|
|
134 |
C |
p.
|
artikel
|
| 414 |
“Transcranial Direct Current Stimulation and Dual-Task activity in Parkinson's disease" -A pilot study-
|
Antoniotti, P.
|
|
|
134 |
C |
p.
|
artikel
|
| 415 |
Treatment of Parkinsonism through brain stimulation
|
Alimbekova, L.U.
|
|
|
134 |
C |
p.
|
artikel
|
| 416 |
Treatment patterns with long-term foslevodopa/foscarbidopa use in Parkinson’s disease
|
Aldred, J.
|
|
|
134 |
C |
p.
|
artikel
|
| 417 |
Trichloroethylene and its metabolite TaClo lead to degeneration of dopaminergic neurones: Effects in wild type and human A30Pmutant α-synuclein mice
|
Krishnan, K.V.
|
|
|
134 |
C |
p.
|
artikel
|
| 418 |
Understanding patient perceptions of treatment with levodopa–entacapone–carbidopa intestinal infusion – real world insights from the ELEGANCE study
|
Smith, N.
|
|
|
134 |
C |
p.
|
artikel
|
| 419 |
Unrecognized Visual Neurological Disease Late-Onset Niemann-Pick Disease, Type C1
|
Yasar, S.
|
|
|
134 |
C |
p.
|
artikel
|
| 420 |
Utility of clinical tests for asymmetry in Parkinson's disease and Atypical Parkinsonian disorders: the PARK-SYMM scale study.
|
Alvarez, R.M.
|
|
|
134 |
C |
p.
|
artikel
|
| 421 |
Utility of image-based programming (stimview® xt) in patients with advanced parkinson’s disease implanted with a deep brain stimulation system
|
Estrada, M. Blázquez
|
|
|
134 |
C |
p.
|
artikel
|
| 422 |
Utility of intraoperative local field potential for assessing contact selection in Parkinson’s disease with deep brain stimulation
|
Saengphatrachai, W.
|
|
|
134 |
C |
p.
|
artikel
|
| 423 |
Validation of Opal Sensors for Capturing Mobilise-D Digital Mobility Outcomes
|
Sowalsky, K.
|
|
|
134 |
C |
p.
|
artikel
|
| 424 |
Variants of acute parkinsonism with an analysis of the clinical case
|
Karzhaubayeva, M.
|
|
|
134 |
C |
p.
|
artikel
|
| 425 |
What is in a name and what is in the brain? -clinicians’ dilemmas in the biomarker era
|
Novotni, G.
|
|
|
134 |
C |
p.
|
artikel
|
| 426 |
Which aerobic exercise is more effective in Parkinson's patients? Cycle ergometer versus body weight-supported treadmill
|
Tavsan M, Yalcın
|
|
|
134 |
C |
p.
|
artikel
|
| 427 |
Worsening of tremor and myoclonus as delayed sequelae of West Nile virus encephalitis
|
Sarac, I.
|
|
|
134 |
C |
p.
|
artikel
|
| 428 |
Years since Appendectomy Correlates with Decreased Parkinson’s Disease Risk
|
Sandulescu, M.C.
|
|
|
134 |
C |
p.
|
artikel
|
Tijdschrift beschrijving